Erik B Faber

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Bioinformatics Analysis

Top Venues

Journal of medicinal chemistry

JCO precision oncology

ACS chemical biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Erik B Faber, Harris B Krause, Khalid Amin, Philip Walker, Peter J Hosein, Anthony Frank Shields, Heinz-Josef Lenz, Ajay Prakash, Sanjay Goel, Matthew J Oberley, Giuseppe Malleo, Claudio Luchini, Justin H Hwang, Vaia Florou, Ignacio Garrido-Laguna, Emil Lou
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets. JCO precision oncology 8 (2024)
Erik B Faber, Harris B Krause, Khalid Amin, Philip Walker, Peter J Hosein, Anthony Frank Shields, Heinz-Josef Lenz, Ajay Prakash, Sanjay Goel, Matthew J Oberley, Giuseppe Malleo, Claudio Luchini, Justin H Hwang, Vaia Florou, Ignacio Garrido-Laguna, Emil Lou
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets. JCO precision oncology 8 (2024)
Erik B Faber, Harris B Krause, Khalid Amin, Philip Walker, Peter J Hosein, Anthony Frank Shields, Heinz-Josef Lenz, Ajay Prakash, Sanjay Goel, Matthew J Oberley, Giuseppe Malleo, Claudio Luchini, Justin H Hwang, Vaia Florou, Ignacio Garrido-Laguna, Emil Lou
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets. JCO precision oncology 8 (2024)
Erik B Faber, Nan Wang, Kristen John, Luxin Sun, Henry L Wong, David Burban, Rawle Francis, Defeng Tian, Kwon H Hong, An Yang, Liming Wang, Mazen Elsaid, Hira Khalid, Nicholas M Levinson, Ernst K Schonbrunn, Jon E Hawkinson, Gunda I Georg
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice. Journal of medicinal chemistry 66 (3) (2023)
Erik B Faber, Luxin Sun, Jian Tang, Emily R Roberts, Sornakala Ganeshkumar, Nan Wang, Damien M Rasmussen, Abir Majumdar, Laura E Hirsch, Kristen John, An Yang, Hira Khalid, Jon E Hawkinson, Nicholas M Levinson, Vargheese M Chennthukuzhi, Daniel A Harki, Ernst K Schonbrunn, Gunda I Georg
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding. Nature communications 14 (1) (2023)
Erik B Faber, Nan Wang, Kristen John, Luxin Sun, Henry L Wong, David Burban, Rawle Francis, Defeng Tian, Kwon H Hong, An Yang, Liming Wang, Mazen Elsaid, Hira Khalid, Nicholas M Levinson, Ernst K Schonbrunn, Jon E Hawkinson, Gunda I Georg
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice. Journal of medicinal chemistry 66 (3) (2023)
Erik B Faber, Nan Wang, Kristen John, Luxin Sun, Henry L Wong, David Burban, Rawle Francis, Defeng Tian, Kwon H Hong, An Yang, Liming Wang, Mazen Elsaid, Hira Khalid, Nicholas M Levinson, Ernst K Schonbrunn, Jon E Hawkinson, Gunda I Georg
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice. Journal of medicinal chemistry 66 (3) (2023)
Erik B Faber, Nan Wang, Kristen John, Luxin Sun, Henry L Wong, David Burban, Rawle Francis, Defeng Tian, Kwon H Hong, An Yang, Liming Wang, Mazen Elsaid, Hira Khalid, Nicholas M Levinson, Ernst K Schonbrunn, Jon E Hawkinson, Gunda I Georg
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice. Journal of medicinal chemistry (2023)
Erik B Faber, Defeng Tian, David Burban, Nicholas M Levinson, Jon E Hawkinson, Gunda I Georg
Cooperativity Between Orthosteric Inhibitors and Allosteric Inhibitor 8-Anilino-1-Naphthalene Sulfonic Acid (ANS) in Cyclin-Dependent Kinase 2. ACS chemical biology 15 (7) (2020)
Erik B Faber, Gunda I Georg
DFG-1 Binding: A New Residue for Developing Selective Kinase Inhibitors. Journal of medicinal chemistry 63 (18) (2020)